Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
The Medical Journal of Australia
|
November 16, 2025
The CURE Asthma roadmap
Gary P Anderson, Anthony Flynn, Phil G Bardin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 17, 2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Joan T Merrill, Joel Guthridge, Miles Smith, et al.
Brain : a Journal of Neurology
|
April 25, 2025
Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination
Ahmed Abdelhak, Christian Cordano, Greg J Duncan, et al.
PLOS Digital Health
|
April 17, 2024
Large language models approach expert-level clinical knowledge and reasoning in ophthalmology: A head-to-head cross-sectional study
Arun James Thirunavukarasu, Shathar Mahmood, Andrew Malem, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway
Peiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Nature
|
July 1, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
Toni K Choueiri, Jamie Merchan, Amita Patnaik, et al.
Molecular Cancer Therapeutics
|
February 1, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models
Paul Foster, Kyoko Yamaguchi, Pin P Hsu, et al.
Journal of Medicinal Chemistry
|
February 12, 2013
Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR)
Craig S Takeuchi, Byung Gyu Kim, Charles M Blazey, et al.
Journal of Medicinal Chemistry
|
May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors
James W Leahy, Chris A Buhr, Henry W B Johnson, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
The Medical Journal of Australia
|
November 16, 2025
The CURE Asthma roadmap
Gary P Anderson, Anthony Flynn, Phil G Bardin, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
July 17, 2023
Obexelimab in Systemic Lupus Erythematosus With Exploration of Response Based on Gene Pathway Co-Expression Patterns: A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial
Joan T Merrill, Joel Guthridge, Miles Smith, et al.
Brain : a Journal of Neurology
|
April 25, 2025
Markers of axonal injury in blood and tissue triggered by acute and chronic demyelination
Ahmed Abdelhak, Christian Cordano, Greg J Duncan, et al.
PLOS Digital Health
|
April 17, 2024
Large language models approach expert-level clinical knowledge and reasoning in ophthalmology: A head-to-head cross-sectional study
Arun James Thirunavukarasu, Shathar Mahmood, Andrew Malem, et al.
Molecular Cancer Therapeutics
|
March 18, 2014
Characterization of the activity of the PI3K/mTOR inhibitor XL765 (SAR245409) in tumor models with diverse genetic alterations affecting the PI3K pathway
Peiwen Yu, A Douglas Laird, Xiangnan Du, et al.
Nature
|
July 1, 2026
Casdatifan shows durable response linked to HIF-2α biology in kidney cancer
Toni K Choueiri, Jamie Merchan, Amita Patnaik, et al.
Molecular Cancer Therapeutics
|
February 1, 2015
The Selective PI3K Inhibitor XL147 (SAR245408) Inhibits Tumor Growth and Survival and Potentiates the Activity of Chemotherapeutic Agents in Preclinical Tumor Models
Paul Foster, Kyoko Yamaguchi, Pin P Hsu, et al.
Journal of Medicinal Chemistry
|
February 12, 2013
Discovery of a novel class of highly potent, selective, ATP-competitive, and orally bioavailable inhibitors of the mammalian target of rapamycin (mTOR)
Craig S Takeuchi, Byung Gyu Kim, Charles M Blazey, et al.
Journal of Medicinal Chemistry
|
May 3, 2012
Discovery of a novel series of potent and orally bioavailable phosphoinositide 3-kinase γ inhibitors
James W Leahy, Chris A Buhr, Henry W B Johnson, et al.
Page
of 8